ICMR to examine antibodies to corona vaccine given in Patna AIIMS

People involved in the corona vaccine trial in Patna AIIMS are healthy. Fourteen days after the vaccine, her antibody screening has begun. A sample of 30 such people has been sent to ICMR. A sample of the remaining 20 people will also be sent soon.

According to the rules, the sample of these people will be sent again after 28 days of taking the vaccine. After studying these samples, only the ICMR will explain how effective the vaccine was. The vaccine is successful or unsuccessful in the trial. A preferred doctor in the vaccine trial team said that in the first phase, the vaccine can be considered successful in the sense that no side effects were seen in any of the people who were given the vaccine. Neither has anyone been ill in any way.

ICMR to examine antibodies to corona vaccine given in Patna AIIMS

AIIMS Director Dr. PK Singh said that AIIMS Patna was entrusted with the task of providing vaccines and monitoring them. Under the supervision of Superintendent Dr. CM Singh, a medical team is monitoring the vaccine to people taking the vaccine.

First trial started in Patna AIIMS

The vaccine trial first started in Patna AIIMS. The first dose of vaccine in Patna AIIMS started on 14 July. Between 15 and 22 July, 38 people were given the vaccine dose. Meanwhile 12 more people came forward for the vaccine trial. The work of giving them the vaccine started from 29 July. In this way the first dose was given to a total of 50 people.

Hyderabad-based company has made a vaccine

Actually, the vaccine is under trial under the supervision of ICMR. The samples will be studied in ICMR's labs in Pune or Delhi. The vaccine is manufactured by Bharat Biotech Company of Hyderabad. It has just been named Covacs. At Patna AIIMS, the trial process of the vaccine was first started in the entire country from July 7. However, the first dosing process started on 14-15 July.

LUPIN launches Corona drug 'Coviholt' in India

Drug manufacturer Lupin on Wednesday announced the launch of the antiviral drug Favipiravir for the treatment of patients with mild to moderate symptoms of coronavirus in India. A tablet of this drug released in the name of Covihalt has been priced at Rs 49 in India.

200 mg one tablet

Lupin said in a regulatory filing that it had received approval from the Drug Controller General of India (DCGI) for the emergency use of favipiravir. According to the company, Favipiravir will be launched at 200 mg per tablet. It will be available as a strip of 10 tablets and will be priced at Rs 49 per tablet.

Favipiravir is an anti-viral drug

Favipiravir is the only oral anti-viral drug approved for the treatment of patients with mild to moderate corona virus. The company said that the strength of its Coviholt dose has been developed keeping in mind the convenience of administration.

Company has strong distribution network

Rajiv Sibal, president of Lupine's India Region Formulation (IRF), said the company has good experience in the field of rapidly spreading infection diseases such as tuberculosis. Hopefully the company will be able to take advantage of it. We will be able to ensure Covihalt's reach across the country due to our strong distribution network and the workforce working in the field.

Sun Pharma's 'Fluguard' for Rs 35

Earlier on 4 August, Sun Pharmaceutical Industries launched Favipiravir in the market as 'Fluguard'. This is by far the cheapest version of favipivir in India. Sun Pharma has priced its tablet at Rs 35. On behalf of Sun Pharma, it was said that more than 50,000 cases of Covid-19 are being reported daily in India. There is an urgent need to provide more options to physicians for their treatment. Sun Pharma is the fourth largest generic and world's top pharmaceutical company in the world.

Corona infection can be treated with the help of another medicine

Scientists from all over the world are currently trying to find the bite of the coronavirus (COVID-19). In this exercise, scientists have seen the possibility of competing against corona in another existing medicine. They claim that drugs used to help relieve alcohol addiction may be effective against Corona. The disease can be treated with the help of these medicines.

According to researchers at the Russian National Research University Higher School of Economics, with the help of these potential drugs, structural elements of the coronavirus can be absorbed in the treatment. In a study published in the journal Mendeleev Communications, researchers said that a protein called M-Pro has an important role in replicating the coronavirus. By curbing this ability, replication of the corona inside the body can be completely stopped. This dangerous virus infects human cells in this way.

The severity of the virus can be reduced

The drug was tested with drugs approved by the American Food and Drug Administration to get rid of alcohol addiction. Researchers reported that commonly used drugs to relieve alcohol addiction were found to be effective in combating corona in two ways. This can reduce symptoms as well as reduce the severity of the virus. He said that more research needs to be done regarding these drugs. Earlier studies have also revealed the treatment of coronavirus with many existing drugs.

Corona's havoc continues across the world

Please tell that Corona is playing havoc all over the world. Its first case was reported in December last year in Wuhan, China. Since then about one crore 90 lakh people have been infected all over the world and seven lakh people have died. America has been the most affected by this. So far, about 50 lakh cases have been reported here and about one lakh 60 thousand people have died.

Corona vaccine found to be effective in tests on mice

The Corona vaccine from the American company Moderna has proved successful in testing on mice. Tests on mice in a clinical trial of Moderna's vaccine found that it protects against virus infection. According to the findings published in the journal Nature, neutrophizing antibodies in mice when given two doses of 1-microgram (MCG) as intramuscular injection.

ICMR to examine antibodies to corona vaccine given in Patna AIIMS

MCG injections were given to mice in additional experiments. Research has found that immunity persisted for seven weeks after taking a single dose of a possible corona vaccine or 10 mg of mRNA-1273 in mice.

This vaccine was protected against viral replication in the lungs in mice. NIAID Vaccine Research Center scientists worked with investigators at the University of Texas to identify the atomic structure of the spike protein on the surface of the virus.

Strong CD8 T-cells were developed

Vaccines have been found to produce strong CD8 T-cells in mice. It does not induce the type of cellular immune response that is associated with vaccine-associated respiratory disease. They stated that this rare, allergic-type inflammation was seen in the 1960s in individuals vaccinated with a whole inactivated respiratory synchrosial virus (RSV) vaccine.

World Health Organization- Corona vaccine will change rapidly in the world if everyone gets together

The World Health Organization (WHO) Director-General Tedros Adhanom Ghebreyesus said on Thursday that if any corona vaccine in the world is made publicly available to all, then worldwide economic reforms can happen rapidly.

ICMR to examine antibodies to corona vaccine given in Patna AIIMS

Tedros said that sharing a vaccine or sharing other devices really helps the world recover together. Economic recovery can occur rapidly and corona may reduce losses. He said that nationalism about vaccine is not good, it will not help us. Tedros said on Monday that the coronavirus is the largest health emergency since the early 20th century, but the discovery of the vaccine is unprecedented.

Significantly, when asked by WHO emergency director Michael Ryan about a proposed Russian vaccine, he told the panel that the results of the trial would be needed to make any vaccine safe and effective. He said that no country will be safe till we are all safe. Ryan also said that authorities should be able to demonstrate the coronavirus vaccine to be effective through clinical trials rather than human challenge studies.

Followed By:-

Facebook Page:- https://www.facebook.com/coronavirus237

Twitter:- https://twitter.com/AmberAg22607979

Instagram:- https://www.instagram.com/amber_aga